Choroid plexus papillomas: Advances in molecular biology and understanding of tumorigenesis

Neuro-Oncology

Volumn 15, Issue 3, 2013, Pages 255-267

  Safaee, Michael ^a   Oh, Michael C ^a   Bloch, Orin ^a   Sun, Matthew Z ^a   Kaur, Gurvinder ^a   Auguste, Kurtis I ^a   Tihan, Tarik ^b   Parsa, Andrew T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

choroid plexus papilloma; choroid plexus tumor; diagnosis; treatment; tumorigenesis

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; NOTCH3 RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; BRAIN SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER GENETICS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOGENESIS; CHOROID PLEXUS PAPILLOMA; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; COMPUTER ASSISTED TOMOGRAPHY; EPIGENETICS; HISTOPATHOLOGY; HUMAN; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL TRANSDUCTION; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MOLECULAR BIOLOGY; PAPILLOMA, CHOROID PLEXUS;

EID: 84874524440     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos289     Document Type: Article

References (151)

1. Wolburg H, Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol. 2010;119(1):75-88.
2. Cataltepe O, Liptzin D, Jolley L, Smith TW. Diffuse villous hyperplasia of the choroid plexus and its surgical management. J Neurosurg Pediatr. 2010;5(5):518-522.
3. Janisch W, Staneczek W. [Primary tumors of the choroid plexus. Frequency, localization and age]. Zentralbl Allg Pathol. 1989;135(3): 235-240.
4. Rickert CH, Paulus W. Tumors of the choroid plexus. Microsc Res Tech. 2001;52(1):104-111. (Pubitemid 32065033)
5. Wolff JE, Sajedi M, Brant R, Coppes MJ, Egeler RM. Choroid plexus tumours. Br J Cancer. 2002;87(10):1086-1091. (Pubitemid 35418102)
6. Paulus W, Bradner S. WHO Classification of Tumours of the Central Nervous System. Lyon: IARC Press; 2007.
7. Tacconi L, Delfini R, Cantore G. Choroid plexus papillomas: consideration of a surgical series of 33 cases. Acta neurochirurgica. 1996;138(7):802-810. (Pubitemid 26238131)
8. Jooma R, Hayward RD, Grant DN. Intracranial neoplasms during the first year of life: analysis of one hundred consecutive cases. Neurosurgery. 1984;14(1):31-41. (Pubitemid 14224323)
9. Hopper KD, Foley LC, Nieves NL, Smirniotopoulos JG. The interventricular extension of choroid plexus papillomas. AJNR Am J Neuroradiol. 1987;8(3):469-472. (Pubitemid 17075734)
10. Kimura M, Takayasu M, Suzuki Y, et al. Primary choroid plexus papilloma located in the suprasellar region: case report. Neurosurgery. 1992;31(3):563-566.
11. Kurtkaya-Yapicier O, Scheithauer BW, Van Peteghem KP, Sawicki JE. Unusual case of extradural choroid plexus papilloma of the sacral canal. Case report. J Neurosurg. 2002;97(1 suppl):102-105. (Pubitemid 34686609)
12. Pillai A, Rajeev K, Chandi S, Unnikrishnan M. Intrinsic brainstem choroid plexus papilloma. Case report. J Neurosurg. 2004;100(6):1076-1078. (Pubitemid 38661622)
13. Krul JM, Gooskens RH, Ramos L, Veiga-Pires JA. Ultrasound detection of a choroid plexus papilloma of the third ventricle. J Neuroradiol. 1987;14(2):179-182. (Pubitemid 17145720)
14. Veyrac C, Couture A. Normal and pathologic choroid plexus ultrasound. Annales de radiologie. 1985;28(3-4):215-223. (Pubitemid 15078686)
15. Anselem O, Mezzetta L, Grange G, et al. Fetal tumors of the choroid plexus: is differential diagnosis between papilloma and carcinoma possible? Ultrasound Obstet Gynecol. 2011;38(2):229-232.
16. Hartge DR, Axt-Fliedner R,Weichert J. Prenatal diagnosis and successful postnatal therapy of an atypical choroid plexus papilloma. Case report and review of literature. J Clin Ultrasound. 2010;38(7):377-383.
17. Gaudio RM, Tacconi L, Rossi ML. Pathology of choroid plexus papillomas: a review. Clin Neurol Neurosurg. 1998;100(3):165-186. (Pubitemid 28479836)
18. Due-Tonnessen B, Helseth E, Skullerud K, Lundar T. Choroid plexus tumors in children and young adults: report of 16 consecutive cases. Childs Nerv Syst. 2001;17(4-5):252-256. (Pubitemid 32447691)
19. Krishnan S, Brown PD, Scheithauer BW, Ebersold MJ, Hammack JE, Buckner JC. Choroid plexus papillomas: a single institutional experience. J Neurooncol. 2004;68(1):49-55. (Pubitemid 39137351)
20. Watanabe K, Ando Y, Iwanaga H, et al. Choroid plexus papilloma containing melanin pigment. Clin Neuropathol. 1995;14(3):159-161.
21. Corcoran GM, Frazier SR, Prayson RA. Choroid plexus papilloma with osseous and adipose metaplasia. Ann Diagn Pathol. 2001;5(1):43-47. (Pubitemid 32178957)
22. Tena-Suck ML, Lopez-Gomez M, Salinas-Lara C, Arce-Arellano RI, Biol AS, Renbao-Bojorquez D. Psammomatous choroid plexus papilloma: three cases with atypical characteristics. Surg Neurol. 2006;65(6): 604-610. (Pubitemid 43729603)
23. Aquilina K, Nanra JS, Allcutt DA, Farrell M. Choroid plexus adenoma: case report and review of the literature. Childs Nerv Syst. 2005;21(5): 410-415. (Pubitemid 41372165)
24. Buccoliero AM, Bacci S, Mennonna P, Taddei GL. Pathologic quiz case: infratentorial tumor in a middle-aged woman. Oncocytic variant of choroid plexus papilloma. Arch Pathol Lab Med. 2004;128(12): 1448-1450. (Pubitemid 39627488)
25. SarkarC, SharmaMC,Gaikwad S,SharmaC, SinghVP.Choroid plexus papilloma: a clinicopathological study of 23 cases. Surg Neurol. 1999;52(1): 37-39. (Pubitemid 29297500)
26. Ikota H, Tanaka Y, Yokoo H, Nakazato Y. Clinicopathological and immunohistochemical study of 20 choroid plexus tumors: their histological diversity and the expression of markers useful for differentiation from metastatic cancer. Brain Tumor Pathol. 2011;28(3):215-221.
27. Jeibmann A, Hasselblatt M, Gerss J, et al. Prognostic implications of atypical histologic features in choroid plexus papilloma. J Neuropathol Exp Neurol. 2006;65(11):1069-1073. (Pubitemid 44684664)
28. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109. (Pubitemid 47103521)
29. Keating RF, Goodrich JT, Packer RJ. Tumors of the Pediatric Central Nervous System. 1st ed. New York: Thieme; 2001.
30. Levy ML, Goldfarb A, Hyder DJ, et al. Choroid plexus tumors in children: significance of stromal invasion. Neurosurgery. 2001;48(2): 303-309. (Pubitemid 32164868)
31. Jinhu Y, Jianping D, Jun M, Hui S, Yepeng F. Metastasis of a histologically benign choroid plexus papilloma: case report and review of the literature. J Neurooncol. 2007;83(1):47-52. (Pubitemid 46647164)
32. McCall T, Binning M, Blumenthal DT, Jensen RL. Variations of disseminated choroid plexus papilloma: 2 case reports and a review of the literature. Surg Neurol. 2006;66(1):62-67; discussion 67-68.
33. Jeibmann A, Wrede B, Peters O, Wolff JE, Paulus W, Hasselblatt M. Malignant progression in choroid plexus papillomas. J Neurosurg. 2007;107(3 suppl):199-202.
34. Shibahara J, Kashima T, Kikuchi Y, Kunita A, Fukayama M. Podoplanin is expressed in subsets of tumors of the central nervous system. Virchows Arch. 2006;448(4):493-499.
35. Ang LC, Taylor AR, Bergin D, Kaufmann JC. An immunohistochemical study of papillary tumors in the central nervous system. Cancer. 1990;65(12):2712-2719. (Pubitemid 20179548)
36. Paulus W, Janisch W. Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases. Acta Neuropathol. 1990;80(6):635-641. (Pubitemid 20342505)
37. Kepes JJ, Collins J. Choroid plexus epithelium (normal and neoplastic) expresses synaptophysin. A potentially useful aid in differentiating carcinoma of the choroid plexus from metastatic papillary carcinomas. J Neuropathol Exp Neurol. 1999;58(4):398-401. (Pubitemid 29187902)
38. Hasselblatt M, Bohm C, Tatenhorst L, et al. Identification of novel diagnostic markers for choroid plexus tumors: a microarray-based approach. Am J Surg Pathol. 2006;30(1):66-74. (Pubitemid 43740211)
39. Jellinek DA, Chang AC, Larsen MR, Wang X, Robinson PJ, Reddel RR. Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. Biochem J. 2000;350(Pt 2):453-461.
40. Yoshiko Y, Aubin JE. Stanniocalcin 1 as a pleiotropic factor in mammals. Peptides. 2004;25(10):1663-1669. (Pubitemid 39346208)
41. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC. Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci USA. 2000;97(7):3637-3642. (Pubitemid 30183355)
42. Gyure KA, Morrison AL. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas. Mod Pathol. 2000;13(6):638-643. (Pubitemid 30436800)
43. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem. 1995;3:99-107.
44. Miettinen M. Keratin immunohistochemistry: update of applications and pitfalls. Pathol Annu. 1993;28(Pt 2):113-143.
45. Ramaekers F, van Niekerk C, Poels L, et al. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol. 1990;136(3):641-655. (Pubitemid 20105931)
46. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol. 1995;8(4):384-388.
47. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992;140(2):427-447.
48. Beschorner R, Schittenhelm J, Schimmel H, et al. Choroid plexus tumors differ from metastatic carcinomas by expression of the excitatory amino acid transporter-1. Hum Pathol. 2006;37(7):854-860. (Pubitemid 43922376)
49. Gottschalk J, Jautzke G, Paulus W, Goebel S, Cervos-Navarro J. The use of immunomorphology to differentiate choroid plexus tumors from metastatic carcinomas. Cancer. 1993;72(4):1343-1349. (Pubitemid 23225007)
50. Figarella-Branger D, Lepidi H, Poncet C, et al. Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors. Acta Neuropathol. 1995;89(3):248-257.
51. Furness PN, Lowe J, Tarrant GS. Subepithelial basement membrane deposition and intermediate filament expression in choroid plexus neoplasms and ependymomas. Histopathology. 1990;16(3):251-255. (Pubitemid 20113523)
52. Ishizawa K, Komori T, Shimada S, Hirose T. Podoplanin is a potential marker for the diagnosis of ependymoma: a comparative study with epithelial membrane antigen (EMA). Clin Neuropathol. 2009;28(5): 373-378.
53. Hasselblatt M, Blumcke I, Jeibmann A, et al. Immunohistochemical profile and chromosomal imbalances in papillary tumours of the pineal region. Neuropathol Appl Neurobiol. 2006;32(3):278-283.
54. Jouvet A, Fauchon F, Liberski P, et al. Papillary tumor of the pineal region. Am J Surg Pathol. 2003;27(4):505-512. (Pubitemid 36368549)
55. Shibahara J, Todo T, Morita A, Mori H, Aoki S, Fukayama M. Papillary neuroepithelial tumor of the pineal region. A case report. Acta Neuropathol. 2004;108(4):337-340. (Pubitemid 39317701)
56. Judkins AR, Burger PC, Hamilton RL, et al. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol. 2005;64(5):391-397. (Pubitemid 40629129)
57. Matsushima T, Inoue T, Takeshita I, Fukui M, Iwaki T, Kitamoto T. Choroid plexus papillomas: an immunohistochemical study with particular reference to the coexpression of prealbumin. Neurosurgery. 1988;23(3):384-389.
58. Menon G, Nair SN, Baldawa SS, Rao RB, Krishnakumar KP, Gopalakrishnan CV. Choroid plexus tumors: an institutional series of 25 patients. Neurol India. 2010;58(3):429-435.
59. Barreto AS, Vassallo J, Queiroz Lde S. Papillomas and carcinomas of the choroid plexus: histological and immunohistochemical studies and comparison with normal fetal choroid plexus. Arq Neuropsiquiatr. 2004;62(3A):600-607. (Pubitemid 39295526)
60. Kato T, Fujita M, Sawamura Y, et al. Clinicopathological study of choroid plexus tumors: immunohistochemical features and evaluation of proliferative potential by PCNA and Ki-67 immunostaining. Noshuyo Byori. 1996;13(2):99-105.
61. Qualman SJ, Shannon BT, Boesel CP, Jacobs D, Jinkens C, Hayes J. Ploidy analysis and cerebrospinal fluid nephelometry as measures of clinical outcome in childhood choroid plexus neoplasia. Pathol Annu. 1992;27(Pt 1):305-320.
62. Tabori U, Shlien A, Baskin B, et al. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol. 2010;28(12):1995-2001.
63. Wrede B, Hasselblatt M, Peters O, et al. Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study. J Neurooncol. 2009;95(3):383-392.
64. Vajtai I, Varga Z, Aguzzi A. MIB-1 immunoreactivity reveals different labelling in low-grade and in malignant epithelial neoplasms of the choroid plexus. Histopathology. 1996;29(2):147-151. (Pubitemid 26264439)
65. Carlotti CG, Jr, Salhia B, Weitzman S, et al. Evaluation of proliferative index and cell cycle protein expression in choroid plexus tumors in children. Acta Neuropathol. 2002;103(1):1-10. (Pubitemid 36075306)
66. Tena-Suck ML, Salinas-Lara C, Rembao-Bojorquez D, Castillejos M. Clinicopathologic and immunohistochemical study of choroid plexus tumors: single-institution experience in Mexican population. J Neurooncol. 2010;98(3):357-365.
67. Ohgaki H, Eibl RH, Schwab M, et al. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog. 1993;8(2):74-80. (Pubitemid 23296312)
68. Jay V, Ho M, Chan F, Malkin D. P53 expression in choroid plexus neoplasms: an immunohistochemical study. Arch Pathol Lab Med. 1996;120(11):1061-1065. (Pubitemid 26382884)
69. Mueller W, Eum JH, Lass U, et al. No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma. Neuropathol Appl Neurobiol. 2004;30(3):304-307. (Pubitemid 38789251)
70. Rutherford J, Chu CE, Duddy PM, et al. Investigations on a clinically and functionally unusual and novel germline p53 mutation. Br J Cancer. 2002;86(10):1592-1596. (Pubitemid 34628113)
71. Gozali AE, Britt B, Shane L, et al. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010. Pediatr Blood Cancer. 2012;58(6):905-909.
72. Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer. 2009;9(2):95-107.
73. Tabori U, Malkin D. Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li-Fraumeni syndrome. Cancer Res. 2008;68(7):2053-2057. (Pubitemid 351521773)
74. Custodio G, Taques GR, Figueiredo BC, et al. Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil. PloS One. 2011;6(3):e18015.
75. Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA. 2001;98(16):9330-9335. (Pubitemid 32743916)
76. Aicardi J. Aicardi syndrome. Brain Dev. 2005;27(3):164-171. (Pubitemid 40312026)
77. Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet. 1999;65(5): 1342-1348. (Pubitemid 30460384)
78. Muchardt C, Sardet C, Bourachot B, Onufryk C, Yaniv M. A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. Nucleic Acids Res. 1995;23(7): 1127-1132.
79. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394(6689):203-206. (Pubitemid 28325977)
80. Wade PA, Wolffe AP. Transcriptional regulation: SWItching circuitry. Curr Biol. 1999;9(6):R221-R224. (Pubitemid 29181832)
81. Sevenet N, Lellouch-Tubiana A, Schofield D, et al. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet. 1999;8(13):2359-2368.
82. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med. 1992;326(15): 988-993.
83. Marks JR, Lin J, Hinds P, Miller D, Levine AJ. Cellular gene expression in papillomas of the choroid plexus from transgenic mice that express the simian virus 40 large T antigen. J Virol. 1989;63(2):790-797. (Pubitemid 19057247)
84. Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF, Jr, Goedert JJ. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA. 1998;279(4): 292-295. (Pubitemid 28071020)
85. Ohgaki H, Huang H, Haltia M, Vainio H, Kleihues P. More about: cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst. 2000;92(6):495-497. (Pubitemid 30182889)
86. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22(10):1276-1312. (Pubitemid 351717519)
87. Enge M, Wilhelmsson U, Abramsson A, et al. Neuron-specific ablation of PDGF-B is compatible with normal central nervous system development and astroglial response to injury. Neurochem Res. 2003;28(2): 271-279. (Pubitemid 36207351)
88. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999;126(14):3047-3055. (Pubitemid 29378170)
89. Kaminski WE, Lindahl P, Lin NL, et al. Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice. Blood. 2001;97(7):1990-1998. (Pubitemid 32239078)
90. Uhrbom L, Hesselager G, Nister M, Westermark B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 1998;58(23):5275-5279. (Pubitemid 28551098)
91. Bruna A, Darken RS, Rojo F, et al. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell. 2007;11(2):147-160. (Pubitemid 46209848)
92. Gerhardt H, Semb H. Pericytes: gatekeepers in tumour cell metastasis? J Mol Med (Berl). 2008;86(2):135-144. (Pubitemid 351172122)
93. Dong J, Grunstein J, Tejada M, et al. VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J. 2004;23(14):2800-2810. (Pubitemid 39013552)
94. Koos B, Paulsson J, Jarvius M, et al. Platelet-derived growth factor receptor expression and activation in choroid plexus tumors. Am J Pathol. 2009;175(4):1631-1637.
95. Hasselblatt M, Mertsch S, Koos B, et al. TWIST-1 is overexpressed in neoplastic choroid plexus epithelial cells and promotes proliferation and invasion. Cancer Res. 2009;69(6):2219-2223.
96. Puisieux A, Valsesia-Wittmann S, Ansieau S. A twist for survival and cancer progression. Br J Cancer. 2006;94(1):13-17. (Pubitemid 43088534)
97. Yoon K, Nery S, Rutlin ML, Radtke F, Fishell G, Gaiano N. Fibroblast growth factor receptor signaling promotes radial glial identity and interacts with Notch1 signaling in telencephalic progenitors. J Neurosci. 2004;24(43):9497-9506. (Pubitemid 39441503)
98. Solecki DJ, Liu XL, Tomoda T, Fang Y, Hatten ME. Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron. 2001;31(4):557-568. (Pubitemid 32835111)
99. Fan X, Mikolaenko I, Elhassan I, et al. Notch1 and Notch2 have opposite effects on embryonal brain tumor growth. Cancer Res. 2004;64(21): 7787-7793. (Pubitemid 39446911)
100. Purow BW, Haque RM, Noel MW, et al. Expression of Notch-1 and its ligands, delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res. 2005;65(6):2353-2363. (Pubitemid 40490146)
101. Dang L, Fan X, Chaudhry A, Wang M, Gaiano N, Eberhart CG. Notch3 signaling initiates choroid plexus tumor formation. Oncogene. 2006;25(3):487-491. (Pubitemid 43117634)
102. Michalowski MB, de Fraipont F, Michelland S, et al. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. Cancer Genet Cytogenet. 2006;166(1):74-81.
103. Song MS, Song SJ, Ayad NG, et al. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol. 2004;6(2):129-137. (Pubitemid 38425712)
104. Pan G, O'Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science. 1997;276(5309):111-113. (Pubitemid 27161256)
105. Badr CE, Wurdinger T, Nilsson J, et al. Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway. Neuro-oncology. 2011;13(11):1213-1224.
106. Losi-Guembarovski R, Kuasne H, Guembarovski AL, Rainho CA, Colus IM. DNA methylation patterns of the CDH1, RARB, and SFN genes in choroid plexus tumors. Cancer Genet Cytogenet. 2007;179(2):140-145. (Pubitemid 350116949)
107. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 2003;94(7):575-581. (Pubitemid 36975010)
108. Soprano DR, Qin P, Soprano KJ. Retinoic acid receptors and cancers. Annu Rev Nutr. 2004;24:201-221. (Pubitemid 38938791)
109. Hermeking H, Lengauer C, Polyak K, et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/Mprogression. Mol Cell. 1997;1(1):3-11. (Pubitemid 127376388)
110. Ferguson AT, Evron E, Umbricht CB, et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA. 2000;97(11):6049-6054. (Pubitemid 30367521)
111. Cao WD, Zhang X, Zhang JN, et al. Immunocytochemical detection of 14-3-3 in primary nervous system tumors. J Neurooncol. 2006;77(2): 125-130. (Pubitemid 44419745)
112. Nass SJ, Herman JG, Gabrielson E, et al. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Res. 2000;60(16): 4346-4348. (Pubitemid 32103608)
113. Bornman DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol. 2001;159(3):831-835. (Pubitemid 32847174)
114. Banelli B, Gelvi I, Di Vinci A, et al. Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors. Oncogene. 2005;24(36):5619-5628. (Pubitemid 43119355)
115. Klein O, Grignon Y, Civit T, Auque J, Marchal JC. [Methylation status of RARbeta gene promoter in low and high grade cerebral glioma. Comparison with normal tissue. Immunohistochemical study of nuclear RARbeta expression in low and high grade cerebral glioma cells. Comparison with normal cells. 48 tumors]. Neuro-Chirurgie. 2005;51(3-4 Pt 1):147-154.
116. Donovan MJ, Yunis EJ, DeGirolami U, Fletcher JA, Schofield DE. Chromosome aberrations in choroid plexus papillomas. Genes Chromosomes Cancer. 1994;11(4):267-270. (Pubitemid 24372152)
117. Rickert CH, Wiestler OD, Paulus W. Chromosomal imbalances in choroid plexus tumors. Am J Pathol. 2002;160(3):1105-1113. (Pubitemid 34224597)
118. Beskonakli E, Cayli S, Bostanci U, Kulacoglu S, Yalcinlar Y. Choroid plexus papillomas of the posterior fossa: extraventricular extension, intraventricular and primary extraventricular location. Report of four cases. J Neurosurg Sci. 1998;42(1):37-40. (Pubitemid 28386993)
119. Mitsuyama T, Ide M, Hagiwara S, Tanaka N, Kawamura H, Aiba M. [Adult choroid plexus papilloma of the posterior fossa: extraventricular location]. No Shinkei Geka. 2005;33(8):825-829. (Pubitemid 41105344)
120. Bonneville F, Sarrazin JL,Marsot-Dupuch K, et al.Unusual lesions of the cerebellopontine angle: a segmental approach. Radiographics. 2001;21(2): 419-438. (Pubitemid 33707768)
121. Li S, Savolaine ER. Imaging of atypical choroid plexus papillomas. Clin Imaging. 1996;20(2):85-90. (Pubitemid 26195668)
122. Bonneville F, Savatovsky J, Chiras J. Imaging of cerebellopontine angle lesions: an update. Part 2: intra-axial lesions, skull base lesions that may invade the CPA region, and non-enhancing extra-axial lesions. Eur Radiol. 2007;17(11):2908-2920. (Pubitemid 47603987)
123. Guermazi A, De Kerviler E, Zagdanski AM, Frija J. Diagnostic imaging of choroid plexus disease. Clin Radiol. 2000;55(7):503-516. (Pubitemid 32054565)
124. Shin JH, Lee HK, Jeong AK, Park SH, Choi CG, Suh DC. Choroid plexus papilloma in the posterior cranial fossa: MR, CT, and angiographic findings. Clin Imaging. 2001;25(3):154-162. (Pubitemid 33001558)
125. Garcia-Valtuille R, Abascal F, Garcia-Valtuille AI, et al. Adult choroid plexus papilloma of the posterior fossa mimicking a hemangioblastoma. Case report. J Neurosurg. 2000;92(5):870-872. (Pubitemid 30243938)
126. Addo NK, Kamaly-Asl ID, Josan VA, Kelsey AM, Estlin EJ. Preoperative vincristine for an inoperable choroid plexus papilloma: a case discussion and review of the literature. J Neurosurg Pediatr. 2011;8(2):149-153.
127. Pencalet P, Sainte-Rose C, Lellouch-Tubiana A, et al. Papillomas and carcinomas of the choroid plexus in children. J Neurosurg. 1998; 88(3):521-528. (Pubitemid 28114726)
128. McEvoy AW, Harding BN, Phipps KP, et al. Management of choroid plexus tumours in children: 20 years experience at a single neurosurgical centre. Pediatr Neurosurg. 2000;32(4):192-199. (Pubitemid 30665910)
129. Nagib MG, O'Fallon MT. Lateral ventricle choroid plexus papilloma in childhood: management and complications. Surg Neurol. 2000;54(5): 366-372. (Pubitemid 32112175)
130. Do HM, Marx WF, Khanam H, Jensen ME. Choroid plexus papilloma of the third ventricle: angiography, preoperative embolization, and histology. Neuroradiology. 2001;43(6):503-506. (Pubitemid 32591080)
131. Di Rocco F, Caldarelli M, Sabatino G, Tamburrini G, Rocco CD. Lateral ventricle choroid plexus papilloma extending into the third ventricle. Pediatr Neurosurg. 2004;40(6):314-316. (Pubitemid 40591512)
132. Otten ML, Riina HA, Gobin YP, Souweidane MM. Preoperative embolization in the treatment of choroid plexus papilloma in an infant. Case report. J Neurosurg. 2006;104(6 suppl):419-421. (Pubitemid 44954817)
133. Picht T, Jansons J, van Baalen A, Harder A, Pietilae TA. Infant with unusually large choroid plexus papilloma undergoing emergency surgery. Case report with special emphasis on the surgical strategy. Pediatr Neurosurg. 2006;42(2):116-121. (Pubitemid 43213926)
134. Wind JJ, Bell RS, Bank WO, Myseros JS. Treatment of third ventricular choroid plexus papilloma in an infant with embolization alone. J Neurosurg Pediatr. 2010;6(6):579-582.
135. Costa JM, Ley L, Claramunt E, Lafuente J. Choroid plexus papillomas of the III ventricle in infants. Report of three cases. Childs Nerv Syst. 1997;13(5):244-249. (Pubitemid 27293382)
136. Guidetti B, Spallone A. The surgical treatment of choroid plexus papillomas: the results of 27 years experience. Neurosurg Rev. 1981;4(3): 129-137.
137. Raimondi AJ, Gutierrez FA. Diagnosis and surgical treatment of choroid plexus papillomas. Childs Brain. 1975;1(2-3):81-115.
138. Schijman E, Monges J, Raimondi AJ, Tomita T. Choroid plexus papillomas of the III ventricle in childhood. Their diagnosis and surgical management. Childs Nerv Syst. 1990;6(6):331-334. (Pubitemid 20338138)
139. Sharma R, Rout D, Gupta AK, Radhakrishnan VV. Choroid plexus papillomas. Br J Neurosurg. 1994;8(2):169-177. (Pubitemid 24160001)
140. Tacconi L, Delfini R, Cantore G. Choroid plexus papillomas: consideration of a surgical series of 33 cases. Acta Neurochir (Wien). 1996; 138(7):802-810. (Pubitemid 26238131)
141. Chow E, Jenkins JJ, Burger PC, et al. Malignant evolution of choroid plexus papilloma. Pediatr Neurosurg. 1999;31(3):127-130. (Pubitemid 30013989)
142. Maria BL, Graham ML, Strauss LC, Wharam MD. Response of a recurrent choroid plexus tumor to combination chemotherapy. J Neurooncol. 1985;3(3):259-262. (Pubitemid 15229835)
143. Valencak J, Dietrich W, Raderer M, et al. Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma. J Neurooncol. 2000;49(3):263-268. (Pubitemid 32106789)
144. Palazzi M, Di Marco A, Campostrini F, Grandinetti A, Bontempini L. The role of radiotherapy in the management of choroid plexus neoplasms. Tumori. 1989;75(5):463-469. (Pubitemid 20064227)
145. Hawkins JC, 3rd. Treatment of choroid plexus papillomas in children: a brief analysis of twenty years' experience. Neurosurgery. 1980;6(4): 380-384.
146. McGirr SJ, Ebersold MJ, Scheithauer BW, Quast LM, Shaw EG. Choroid plexus papillomas: long-term follow-up results in a surgically treated series. J Neurosurg. 1988;69(6):843-849.
147. Talacchi A, De Micheli E, Lombardo C, Turazzi S, Bricolo A. Choroid plexus papilloma of the cerebellopontine angle: a twelve patient series. Surg Neurol. 1999;51(6):621-629. (Pubitemid 29260853)
148. Duke BJ, Kindt GW, Breeze RE. Pineal region choroid plexus papilloma treated with stereotactic radiosurgery: a case study. Comput Aided Surg. 1997;2(2):135-138. (Pubitemid 27413330)
149. Kim IY, Niranjan A, Kondziolka D, Flickinger JC, Lunsford LD. Gamma knife radiosurgery for treatment resistant choroid plexus papillomas. J Neurooncol. 2008;90(1):105-110.
150. Brown WD, Tavare CJ, Sobel EL, Gilles FH. Medulloblastoma and Collins' law: a critical review of the concept of a period of risk for tumor recurrence and patient survival. Neurosurgery. 1995;36(4): 691-697.
151. Buetow PC, Smirniotopoulos JG, Done S. Congenital brain tumors: a review of 45 cases. AJNR Am J Neuroradiol. 1990;11(4):793-799. (Pubitemid 20271190)